PlusTherapeuticsInc . (NASDAQ:PSTV) Stock Price Up 5.2%

PlusTherapeuticsInc . (NASDAQ:PSTV)’s share price rose 5.2% on Monday . The stock traded as high as $2.73 and last traded at $2.45, approximately 976,200 shares traded hands during mid-day trading. An increase of 366% from the average daily volume of 209,441 shares. The stock had previously closed at $2.33.

Separately, ValuEngine upgraded shares of PlusTherapeuticsInc . from a “hold” rating to a “buy” rating in a report on Tuesday, September 24th.

The company has a current ratio of 0.38, a quick ratio of 0.37 and a debt-to-equity ratio of 0.39. The company’s fifty day moving average is $7.71.

PlusTherapeuticsInc . (NASDAQ:PSTV) last released its quarterly earnings results on Thursday, August 15th. The company reported ($5.12) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($9.75) by $4.63. The company had revenue of $0.30 million during the quarter. PlusTherapeuticsInc . had a negative net margin of 492.45% and a negative return on equity of 546.87%.

About PlusTherapeuticsInc . (NASDAQ:PSTV)

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.

Featured Story: How to start trading in the forex market?

Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.